RegeneRx
is a clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of wounds and rare diseases... Read moreRegeneRx
is a clinical-stage biopharmaceutical company that researches and develops novel therapeutics for the treatment of wounds and rare diseases... Read more
News
Oct 03, 2023
Yahoo
RegeneRx: Regen BioPharma, Inc. to Present at the Emerging Growth Conference on October 5, 2023
Sep 28, 2023
Business Wire
Press Release: RegeneRx : Regenerex Pharma, Inc. Corporate and Management Structure Update
Aug 15, 2023
BioSpace
RegeneRx: RegeneRx Effects Reverse Stock Split and Terminates SEC Reporting Obligations
Aug 08, 2023
Citybizlist
RegeneRx: RegeneRx Receives Stockholder Approval for Reverse Stock Split
Aug 01, 2023
MarketScreener
RegeneRx: RegeneRx To Extend Consent Solicitation Vote
May 16, 2023
Owler
Regenerx Biopharmaceuticals Inc: RegeneRx's revenue changed from $76.76K in Dec 2022 to $76.76K in Mar 2023
Apr 14, 2023
Clinical Trials Arena
RegeneRx: RegeneRx enrols first patient in neurotrophic keratitis therapy trial
Apr 12, 2023
Owler
Regenerx Biopharmaceuticals Inc: RegeneRx's employee count changed from 3 in Dec 2021 to 2 in Dec 2022
Apr 11, 2023
MarketScreener
RegeneRx: RegeneRx Issues Letter To Stockholders
Jan 31, 2023
MarketScreener
RegeneRx: Thymosin Beta 4 Research Leads Toward Potential Future Anti-aging Therapy
RegeneRx Competitors
1
2
3
4
5
6
7
8
9
10